×
About 123,860 results

ALLMedicine™ Hepatocellular Carcinoma Center

Research & Reviews  60,713 results

Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Album...
https://doi.org/10.1016/j.jvir.2020.12.023
Journal of Vascular and Interventional Radiology : JVIR; Villalobos A, Cheng B et. al.

Mar 1st, 2021 - To quantify the relationship of the tumor-to-normal ratio (TNR) attained from the technetium-99m macroaggregated albumin (MAA) and posttreatment yttrium-90 bremsstrahlung (Y90-Brem) single-photon emission computerized tomography (SPECT)/computer t...

Laparoscopic Left Hepatectomy with Middle Hepatic Vein Resection for Hepatocellular Car...
https://doi.org/10.12659/AJCR.928801
The American Journal of Case Reports; Umemura A, Nitta H et. al.

Mar 1st, 2021 - BACKGROUND Extrahepatic portal vein obstruction (EHPVO) is one of the most important diseases that causes pre-hepatic portal hypertension, and EHPVO sometimes develops cavernous transformation to maintain hepatopetal flow. In this report, we descr...

see more →

Guidelines  121 results

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

Latin American Association for the study of the liver (ALEH) practice guidance for the ...
https://doi.org/10.1016/j.aohep.2020.09.006
Annals of Hepatology; Arab JP, Dirchwolf M et. al.

Oct 8th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Expert Perspective on ASCO20 Gastrointestinal Cancers Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200231/full/

Jul 1st, 2020 - Donafenib, a deuterated derivative of sorafenib, was tested against sorafenib in the frontline setting in hepatitis B– associated hepatocellular carcinoma (HCC) in a large, multi-institutional study in China (Abstract 4506).

Donafenib Improves OS in Hepatocellular Carcinoma Compared With Sorafenib
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200179/full/

May 28th, 2020 - Donafenib significantly improved overall survival (OS) rates compared with sorafenib in patients with hepatocellular carcinoma (HCC) and did so with favorable safety and tolerability, according to a new study (Abstract 4506).

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with...
https://doi.org/10.1016/j.annonc.2019.12.001
Annals of Oncology : Official Journal of the European Soc... Chen LT, Martinelli E et. al.

Feb 18th, 2020 - The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma (HCC) was published in 2018, and covered the diagnosis, management, tre...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  61,857 results

Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Album...
https://doi.org/10.1016/j.jvir.2020.12.023
Journal of Vascular and Interventional Radiology : JVIR; Villalobos A, Cheng B et. al.

Mar 1st, 2021 - To quantify the relationship of the tumor-to-normal ratio (TNR) attained from the technetium-99m macroaggregated albumin (MAA) and posttreatment yttrium-90 bremsstrahlung (Y90-Brem) single-photon emission computerized tomography (SPECT)/computer t...

Laparoscopic Left Hepatectomy with Middle Hepatic Vein Resection for Hepatocellular Car...
https://doi.org/10.12659/AJCR.928801
The American Journal of Case Reports; Umemura A, Nitta H et. al.

Mar 1st, 2021 - BACKGROUND Extrahepatic portal vein obstruction (EHPVO) is one of the most important diseases that causes pre-hepatic portal hypertension, and EHPVO sometimes develops cavernous transformation to maintain hepatopetal flow. In this report, we descr...

see more →

News  1,147 results

ASCO Announces New Advanced Liver Cancer Guidelines
https://www.medscape.com/viewarticle/946306

Feb 22nd, 2021 - New guidelines from the American Society of Clinical Oncology were released to address the treatment of advanced hepatocellular carcinoma (HCC). An unprecedented number of new agents have been approved for systemic therapy of HCC in recent years, ...

TACTICS: TACE Plus Sorafenib Improves PFS in Unresectable HCC
https://www.medscape.com/viewarticle/945041

Jan 31st, 2021 - Combining transcatheter arterial chemoembolization (TACE) therapy with sorafenib improved progression-free survival (PFS), but not overall survival (OS), when compared with TACE alone in patients with unresectable hepatocellular carcinoma (HCC), f...

Lasting Benefit With Nivo Plus Ipi in Advanced Liver Cancer
https://www.medscape.com/viewarticle/945046

Jan 31st, 2021 - Long-term follow-up data show a continued benefit for patients with advanced hepatocellular carcinoma (HCC) treated with nivolumab and ipilimumab after disease progression on sorafenib, according to investigators from the Checkmate 040 trial. At a...

USPSTF Reaffirms Advice on HBV Screening in High-Risk Individuals
https://www.medscape.com/viewarticle/942681

Dec 15th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...

Patients Cured of HCV Still at High Liver Cancer Risk
https://www.medscape.com/viewarticle/941615

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

see more →

Patient Education  5 results see all →